CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Leerink Partners Initiates Rapport Therapeutics at Outperform With $52 Price Target

Positive
AI Analysis

Summary

Leerink Partners initiated coverage of Rapport Therapeutics with an Outperform rating and $52 price target.

Importance:2/10
Sentiment:
0.60
analyst_initiationprice_targetequity_research
Related Companies

Read the original article

Published by yahoo_finance on June 24, 2026 11:37 AM

Read Original